Skip to main content
. 2010 Mar 10;101(6):1562–1569. doi: 10.1111/j.1349-7006.2010.01557.x

Figure 1.

Figure 1

 The expression of SCC‐S2 in primary non‐small‐cell lung cancer tissues (T) and in adjacent noncancerous lung tissues (N) from the same patient. (a) Real‐time PCR analyses of SCC‐S2 mRNA in primary lung cancers and their adjacent normal tissues. Squamous cell carcinoma included cases 2, 3, 5, 7, 8, 9, 11, 13, 14, 15, 19, 22. Adenocarcinoma included cases 1, 4, 6, 10, 12, 16, 17, 18, 20, 21, 23, 24, 25. (b) Expression of SCC‐S2 protein in each of the primary lung tumors (T) and normal lung tissues (N) paired from the same patient by western blotting. (c) SCC‐S2 expression levels were up‐regulated in primary lung cancers (T) in comparison to the paired normal lung tissue (N) from the same patient as examined by immunohistochemistry. SCC‐S2 immunostaining was negative or was detected weakly in adjacent normal bronchial epithelia.